ASLAN Pharmaceuticals (ASLN) Institutional Ownership → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free ASLN Stock Alerts $0.41 -0.01 (-2.38%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ASLAN Pharmaceuticals (NASDAQ:ASLN)CurrentInstitutional OwnershipPercentage58.82%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$3.83MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$6.79M Get ASLN Insider Trade Alerts Want to know when executives and insiders are buying or selling ASLAN Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ASLN Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ASLAN Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023BVF Inc. IL1,049,999$3.83M0.1%N/A6.422% 5/15/2023Temasek Holdings Private Ltd335,615$967K0.0%-80.0%2.406% 5/15/2023Sio Capital Management LLC254,150$732K0.4%-80.0%1.822% 4/19/2023Waterfront Wealth Inc.57,354$165K0.1%-79.6%0.411% 2/15/2023Tang Capital Management LLC5,364,925$1.93M0.3%-5.1%7.692% 1/31/2023Waterfront Wealth Inc.281,775$210K0.1%-21.8%0.404% Get the Latest News and Ratings for ASLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2022Tang Capital Management LLC5,654,925$3.39M0.4%+1.8%8.108% 11/14/2022RTW Investments LP3,015,987$1.81M0.0%-7.2%4.324% 11/3/2022Barclays PLC471,270$283K0.0%-7.4%0.676% 8/16/2022DAFNA Capital Management LLC343,720$170K0.0%+41.0%0.493% 7/25/2022Waterfront Wealth Inc.353,000$175K0.1%+7.3%0.506% 5/13/2022Platinum Investment Management Ltd.145,558$131K0.0%-83.6%0.209% 2/14/2022Waterfront Wealth Inc.270,000$302K0.1%N/A0.711% 2/14/2022 GSA Capital Partners LLP79,368$89K0.0%N/A0.209% 2/11/2022MYDA Advisors LLC170,000$190K0.1%-28.0%0.447% 1/18/2022 CAPROCK Group Inc.34,162$38K0.0%N/A0.090% 11/16/2021Tang Capital Management LLC975,305$1.74M0.4%N/A2.567% 11/16/2021Millennium Management LLC1,468,207$2.61M0.0%+8.8%3.865% 11/15/2021Point72 Asset Management L.P.250,000$445K0.0%N/A0.658% 11/12/2021Affinity Asset Advisors LLC250,000$445K0.1%N/A0.658% 11/12/2021MYDA Advisors LLC236,165$420K0.1%+11.8%0.622% 11/9/2021Barclays PLC188,764$336K0.0%+47.2%0.497% 8/17/2021Logos Global Management LP2,000,000$6.60M0.6%-13.0%5.264% 8/17/2021Millennium Management LLC1,349,288$4.45M0.0%+8.3%3.552% 8/17/2021Atom Investors LP61,507$203K0.0%-24.5%0.162% 8/17/2021Citadel Advisors LLC2,898,298$9.57M0.0%+344.2%7.629% 8/16/2021Schonfeld Strategic Advisors LLC45,500$150K0.0%-9.7%0.120% 8/16/2021Sabby Management LLC765,276$2.53M0.4%-6.3%2.014% 8/16/2021Goldman Sachs Group Inc.412,257$1.36M0.0%+1.2%1.085% 8/13/2021Renaissance Technologies LLC359,649$1.19M0.0%+39.1%0.947% 8/13/2021Jump Financial LLC37,400$123K0.0%N/A0.098% 8/13/2021MYDA Advisors LLC211,165$697K0.2%+5.6%0.556% 8/13/2021Knott David M478,186$1.58M0.6%+9.3%1.259% 8/13/2021Geode Capital Management LLC135,020$445K0.0%+541.9%0.355% 7/31/2021Asymmetry Capital Management L.P.1,194,070$3.94M2.7%-11.7%3.143% 5/19/2021Virtu Financial LLC61,997$208K0.0%+346.2%0.163% 5/19/2021Logos Global Management LP2,300,000$7.71M0.8%N/A6.054% 5/18/2021Millennium Management LLC1,246,275$4.18M0.0%N/A3.280% 5/18/2021Luminus Management LLC1,753,800$5.88M1.1%N/A4.616% 5/18/2021Orbimed Advisors LLC2,520,000$8.44M0.1%N/A6.633% Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is.5/18/2021Citadel Advisors LLC652,511$2.19M0.0%+1,715.3%1.718% 5/17/2021 Vivo Capital LLC2,840,909$9.52M0.3%N/A7.478% 5/17/2021Schonfeld Strategic Advisors LLC50,393$168K0.0%N/A0.133% 5/17/2021 Eudaimonia Partners LLC10,000$34K0.0%N/A0.026% 5/17/2021CSS LLC IL50,000$168K0.0%N/A0.132% 5/17/2021DAFNA Capital Management LLC677,500$2.27M0.5%N/A1.783% 5/17/2021 Caas Capital Management LP150,000$503K0.0%N/A0.395% 5/17/2021Ikarian Capital LLC1,224,516$243K0.0%-39.0%3.223% 5/17/2021Atom Investors LP81,466$273K0.0%N/A0.214% 5/17/2021Goldman Sachs Group Inc.407,464$1.37M0.0%N/A1.073% 5/14/2021RTW Investments LP3,250,000$10.89M0.2%N/A8.555% 5/14/2021Parkman Healthcare Partners LLC325,000$1.09M0.3%N/A0.855% 5/14/2021Monashee Investment Management LLC420,000$1.41M0.2%N/A1.106% 5/13/2021Barclays PLC128,586$431K0.0%N/A0.338% 5/13/2021Renaissance Technologies LLC258,467$866K0.0%-20.5%0.680% 5/13/2021Knott David M437,412$1.47M0.6%N/A1.151% 5/12/2021Geode Capital Management LLC21,036$70K0.0%N/A0.055% 5/12/2021MYDA Advisors LLC200,000$670K0.2%N/A0.526% 5/12/2021JPMorgan Chase & Co.13,905$47K0.0%N/A0.037% 5/11/2021Asymmetry Capital Management L.P.1,352,577$4.53M2.3%N/A3.560% 2/24/2021Virtu Financial LLC13,895$26K0.0%N/A0.037% 2/16/2021Temasek Holdings Private Ltd1,678,075$3.07M0.0%+18.0%5.236% 2/12/2021Ikarian Capital LLC2,006,451$405K0.0%N/A6.260% 2/10/2021Renaissance Technologies LLC324,918$595K0.0%+317.1%1.014% 11/13/2020Platinum Investment Management Ltd.427,141$812K0.0%+2.8%1.333% 5/15/2020DAFNA Capital Management LLC86,082$88K0.0%-26.9%0.269% (Data available from 1/1/2016 forward) ASLN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ASLN shares? During the previous two years, 9 institutional investors and hedge funds held shares of ASLAN Pharmaceuticals. The most heavily invested institutionals were BVF Inc. IL ($3.83M), Tang Capital Management LLC ($1.93M), RTW Investments LP ($1.81M), Temasek Holdings Private Ltd ($967K), Sio Capital Management LLC ($732K), Barclays PLC ($283K), and DAFNA Capital Management LLC ($170K).Learn more on ASLN's institutional investors. What percentage of ASLAN Pharmaceuticals stock is owned by institutional investors? 58.82% of ASLAN Pharmaceuticals stock is owned by institutional investors. Learn more on ASLN's institutional investor holdings. Which institutional investors have been buying ASLAN Pharmaceuticals stock? The following institutional investors have purchased ASLAN Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.05M), DAFNA Capital Management LLC ($100K), Tang Capital Management LLC ($100K), and Waterfront Wealth Inc. ($24K). How much institutional buying is happening at ASLAN Pharmaceuticals? Institutional investors have bought a total of 1,273,999 shares in the last 24 months. This purchase volume represents approximately $4.44M in transactions. Which ASLAN Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold ASLAN Pharmaceuticals stock in the last 24 months: Temasek Holdings Private Ltd ($1.34M), Sio Capital Management LLC ($1.02M), Platinum Investment Management Ltd. ($741.31K), Waterfront Wealth Inc. ($303.15K), Tang Capital Management LLC ($290K), RTW Investments LP ($234.01K), and Barclays PLC ($37.69K). How much institutional selling is happening at ASLAN Pharmaceuticals? Institutional investors have sold a total of 3,965,230 shares in the last 24 months. This volume of shares sold represents approximately $12.25M in transactions. Related Companies: KA Major Shareholders PULM Major Shareholders ENVB Major Shareholders RNAZ Major Shareholders PCSA Major Shareholders LIXT Major Shareholders ADIL Major Shareholders CANF Major Shareholders HEPA Major Shareholders EFTR Major Shareholders This page (NASDAQ:ASLN) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithCollapse of the Petrodollar Colonial MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
